logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10342849 B1

PDFFull Text
Date of Patent:
Jul. 09, 2019

Filed:

Jun. 10, 2016

Antibiotic composition comprising a chemotactic agent and a nutrient dispersion

Applicant:

Professional Compounding Centers of America (Pcca), Houston, TX (US);

Inventor:

Andrew B. Glasnapp, Sugar Land, TX (US);

Assignee:

Professional Compounding Centers of America (PCCA), Houston, TX (US);

Attorneys:

David G. Woodral

GableGotwals

Primary Examiner:

Brian Gangle

Assistant Examiner:

Andrea K McCollum

Int. Cl.
CPC ...
A23L 5/00 (2016.01); A61K 38/06 (2006.01); A61K 38/12 (2006.01); A61K 38/17 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/34 (2017.01); A61K 47/42 (2017.01); A61L 27/16 (2006.01); A61L 27/52 (2006.01); A61L 27/54 (2006.01); A61K 31/202 (2006.01); A61K 31/351 (2006.01); A61K 31/496 (2006.01); A61K 31/5383 (2006.01); A61K 31/7036 (2006.01);
U.S. Cl.
CPC ...
A61K 38/12 (2013.01); A23L 5/00 (2016.08); A61K 31/202 (2013.01); A61K 31/351 (2013.01); A61K 31/496 (2013.01); A61K 31/5383 (2013.01); A61K 31/7036 (2013.01); A61K 38/06 (2013.01); A61K 38/1725 (2013.01); A61K 38/195 (2013.01); A61K 38/2053 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/34 (2013.01); A61K 47/42 (2013.01); A61L 27/16 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); A61L 2430/00 (2013.01); Y02A 50/473 (2018.01);
Abstract

Compositions and methods for treating infectious diseases produced by biofilms are disclosed. More specifically, the present disclosure refers to a pharmaceutical composition which may be used for treating biofilm infections, specifically, biofilms formed by bacteria such as, and other human pathogens. Pharmaceutical compositions may include a nutrient dispersion that can include sodium citrate, succinic acid, xylitol, glutamic acid, and ethylenediaminetetraacetic acid (EDTA), among others. Additionally disclosed pharmaceutical composition may include active pharmaceutical ingredients (API) such as antibiotics. Subsequently, the antibiotics agent may be ciprofloxacin, amikacin, tobramycin, colistin methate, or polymixin, among others. Pharmaceutical compositions disclosed may employ chemotactic agents in order to disrupt biofilms and therefore enhance the antibiotic response. Pharmaceutical compositions disclosed may include suitable vehicles which may depend on the dosage form.

Find Patent Forward Citations

Loading…